Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

Share Price is delayed by 15 minutes
Get Live Data
82.10    -0.90 (-1.08%)
Bid:
81.70
Ask:
82.20
Spread: 0.50 (0.612%)
Market Cap: £230.05m
ESNT Live PriceLast checked at - London Stock Exchange

Intraday Essentra Share Chart

Director/PDMR Shareholding

7 Apr 2026 07:00

RNS Number : 3527Z
Essentra plc
07 April 2026
 

Essentra plc

Directors/Persons Discharging Managerial Responsibility (PDMR)

Notification and public disclosure of transactions by PDMRs

 

The notification below, is made on behalf of PDMRs under article 19.1 of the Market Abuse Regulation ('MAR') and in accordance with Article 19.3 of MAR.

On 31 March 2026, the Company granted Long-Term Incentive Plan (LTIP) awards to PDMRs as set out below. The performance period is three years with a further two- year holding for the Executive Directors, Scott Fawcett and Rowan Baker.

On 31 March 2026. awards under the Deferred Annual Share Bonus (DASB) Plan were also made. These awards normally vest after three years subject to continued service.

The share price used to calculate the number of shares was 90.1p (closing share price at 30 March 2026).

Employee Name

No. of shares 2026 LTIP

No. of shares 2025 DASB

Total shares

Scott Fawcett

Chief Executive Officer

958,381

81,463

1,039,844

Rowan Baker

Chief Financial Officer

732,520

62,265

794,785

Sam Edwards

Chief Digital Information Officer

220,106

9,171

229,277

Richard David Sederman

MD, APAC

198,371

6,918

205,289

Chris Brooks

MD Americas

401,513

8,490

410,003

Shaun Laubscher

Chief People Officer

252,831

0

252,831

Total

 

 

2,932,029

 

1

 

Further details applying to all PDMRs:

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Essentra plc

b)

 

LEI

 

5493007MOZNA03BVNE96

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

a)

 

Description of the financial instrument, type of instrument

Ordinary 25p shares

Identification code

GB00B0744359

b)

 

Nature of the transaction

 

Grant of awards under the Essentra plc 2024 Long Term Incentive Plan and the Deferred Annual Share Bonus Plan.

 

c)

Price(s) and volume(s)

Volume

Price (p)

2,932,029

Nil

d)

 

Aggregated information

- Aggregated volume

- Aggregated Price

As above.

e)

 

Date of the transaction

 

 

07 April 2026

f)

 

Place of the transaction

London Stock Exchange (XLON)

For further enquiries, please contact

Essentra plc

Tim George

Deputy Company Secretary

T: + 44 (0) 1908 359100

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUCACUPQGUQ
Date   Source Headline
5th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSTotal Voting Rights
1st Nov 202411:17 amRNSDirectorate Change
1st Nov 20247:00 amRNSTransaction in Own Shares
30th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSQ3 2024 Trading Update
22nd Oct 20247:00 amRNSTransaction in Own Shares
18th Oct 20247:00 amRNSTransaction in Own Shares
16th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 20249:27 amRNSDirectorate Change
8th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20247:00 amRNSTransaction in Own Shares
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 20249:29 amRNSTotal Voting Rights
1st Oct 20249:14 amRNSTransaction in Own Shares
26th Sep 20247:00 amRNSTransaction in Own Shares
24th Sep 20247:00 amRNSTransaction in Own Shares
23rd Sep 20247:00 amRNSTransaction in Own Shares
19th Sep 20247:00 amRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSTransaction in Own Shares
17th Sep 20247:00 amRNSTrading Update
17th Sep 20247:00 amRNSTransaction in Own Shares
13th Sep 20247:00 amRNSTransaction in Own Shares
10th Sep 20247:00 amRNSDirectorate Change
10th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20247:00 amRNSTotal Voting Rights
30th Aug 20247:00 amRNSTransaction in Own Shares
28th Aug 20247:00 amRNSTransaction in Own Shares
22nd Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20243:50 pmRNSDirector/PDMR Shareholding
6th Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20248:54 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSTransaction in Own Shares
30th Jul 20247:00 amRNSResults for the Half Year Ended 30 June 2024
30th Jul 20247:00 amRNSTransaction in Own Shares
25th Jul 20247:00 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
18th Jul 20247:00 amRNSTransaction in Own Shares
16th Jul 20247:00 amRNSTransaction in Own Shares
11th Jul 20247:00 amRNSTransaction in Own Shares
9th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 20249:11 amRNSNotice of Half Year 2024 Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.